186 related articles for article (PubMed ID: 24405985)
1. Discovery of novel inhibitors of HIV-1 reverse transcriptase through virtual screening of experimental and theoretical ensembles.
Ivetac A; Swift SE; Boyer PL; Diaz A; Naughton J; Young JA; Hughes SH; McCammon JA
Chem Biol Drug Des; 2014 May; 83(5):521-31. PubMed ID: 24405985
[TBL] [Abstract][Full Text] [Related]
2. Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors.
Tabassum T; Azeem SM; Muwonge AN; Frey KM
Curr HIV Res; 2020; 18(4):283-291. PubMed ID: 32493197
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations.
Ivetac A; McCammon JA
J Mol Biol; 2009 May; 388(3):644-58. PubMed ID: 19324058
[TBL] [Abstract][Full Text] [Related]
4. Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques.
Costa G; Rocca R; Corona A; Grandi N; Moraca F; Romeo I; Talarico C; Gagliardi MG; Ambrosio FA; Ortuso F; Alcaro S; Distinto S; Maccioni E; Tramontano E; Artese A
Eur J Med Chem; 2019 Jan; 161():1-10. PubMed ID: 30342421
[TBL] [Abstract][Full Text] [Related]
5. Structural optimization of N
Monforte AM; De Luca L; Buemi MR; Agharbaoui FE; Pannecouque C; Ferro S
Bioorg Med Chem; 2018 Feb; 26(3):661-674. PubMed ID: 29291935
[TBL] [Abstract][Full Text] [Related]
6. Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Chen X; Liu X; Meng Q; Wang D; Liu H; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem Lett; 2013 Dec; 23(24):6593-7. PubMed ID: 24239481
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors.
Sluis-Cremer N; Tachedjian G
Virus Res; 2008 Jun; 134(1-2):147-56. PubMed ID: 18372072
[TBL] [Abstract][Full Text] [Related]
8. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
[TBL] [Abstract][Full Text] [Related]
9. Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Balzarini J
Curr Top Med Chem; 2004; 4(9):921-44. PubMed ID: 15134549
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
Sakakibara N; Hamasaki T; Baba M; Demizu Y; Kurihara M; Irie K; Iwai M; Asada E; Kato Y; Maruyama T
Bioorg Med Chem; 2013 Sep; 21(18):5900-6. PubMed ID: 23916148
[TBL] [Abstract][Full Text] [Related]
11. Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitors.
Stanton RA; Lu X; Detorio M; Montero C; Hammond ET; Ehteshami M; Domaoal RA; Nettles JH; Feraud M; Schinazi RF
Bioorg Med Chem Lett; 2016 Aug; 26(16):4101-5. PubMed ID: 27390064
[TBL] [Abstract][Full Text] [Related]
12. A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity.
Urano E; Miyauchi K; Kojima Y; Hamatake M; Ablan SD; Fudo S; Freed EO; Hoshino T; Komano J
ChemMedChem; 2016 Oct; 11(20):2320-2326. PubMed ID: 27634404
[TBL] [Abstract][Full Text] [Related]
13. F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis.
Lu X; Liu L; Zhang X; Lau TC; Tsui SK; Kang Y; Zheng P; Zheng B; Liu G; Chen Z
Antimicrob Agents Chemother; 2012 Jan; 56(1):341-51. PubMed ID: 22037848
[TBL] [Abstract][Full Text] [Related]
14. Identification of Adjacent NNRTI Binding Pocket in Multi-mutated HIV1- RT Enzyme Model: An in silico Study.
Kamil RF; Debnath U; Verma S; Prabhakar YS
Curr HIV Res; 2018; 16(2):121-129. PubMed ID: 29651941
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016).
Vanangamudi M; Poongavanam V; Namasivayam V
Curr Med Chem; 2017 Nov; 24(34):3774-3812. PubMed ID: 28685686
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.
Chen X; Zhan P; Li D; De Clercq E; Liu X
Curr Med Chem; 2011; 18(3):359-76. PubMed ID: 21143120
[TBL] [Abstract][Full Text] [Related]
17. Novel broad-spectrum thiourea non-nucleoside inhibitors for the prevention of mucosal HIV transmission.
D'Cruz OJ; Uckun FM
Curr HIV Res; 2006 Jul; 4(3):329-45. PubMed ID: 16842085
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase.
Elleder D; Baiga TJ; Russell RL; Naughton JA; Hughes SH; Noel JP; Young JA
Virol J; 2012 Dec; 9():305. PubMed ID: 23231773
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
Meng Q; Chen X; Kang D; Huang B; Li W; Zhan P; Daelemans D; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2016 Jun; 115():53-62. PubMed ID: 26994843
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 RT nonnucleoside inhibitors and their interaction with RT for antiviral drug development.
Zhou Z; Lin X; Madura JD
Infect Disord Drug Targets; 2006 Dec; 6(4):391-413. PubMed ID: 17168804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
